Position in LQDA
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$7,363,675
+$3,167,588 QoQ
Shares Held
195,116
+60.4% QoQ
Ownership
0.219%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 82.25773386088275.ToString("F0")%
Shared 0.ToString("F0")%
None 17.742266139117245.ToString("F0")%
Common Shares in LQDA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026JPMORGAN CHASE & CO holds $2,053,486,049 across 61 Drug Manufacturers - Specialty & Generic names. LQDA ranks #19 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
5,442,067 | $716,937,900 | |
| 2 | ZTS |
Zoetis Inc.
|
3,387,174 | $400,397,831 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
|
6,762,744 | $203,693,847 | |
| 4 | ALKS |
Alkermes plc.
|
4,101,789 | $145,039,257 | |
| 5 | HIMS |
Hims & Hers Health, Inc.
|
5,240,816 | $108,799,337 | |
| 6 | HLN |
Haleon plc
|
8,279,468 | $82,877,469 | |
| 7 | VTRS |
Viatris Inc
|
5,731,565 | $77,433,437 | |
| 8 | RDY |
Dr Reddys Laboratories Ltd
|
4,371,378 | $60,543,580 |
All Filings in LQDA
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $7,363,675 | 195,116 | Shares | Other | 2026-05-13 | |
| 2025-12-31 | $4,196,087 | 121,661 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $634,945 | 27,922 | Shares | Other | 2025-11-26 | |
| 2025-06-30 | $399,093 | 32,030 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $922,212 | 62,523 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $331,689 | 28,205 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $2,353,930 | 235,393 | Shares | Defined | 2024-12-26 | |
| 2024-06-30 | $295,680 | 24,640 | Shares | Defined | 2024-12-26 | |
| 2024-03-31 | $288,967 | 19,591 | Shares | Defined | 2024-12-26 | |
| 2023-12-31 | $377,765 | 31,402 | Shares | Defined | 2024-12-26 | |
| 2023-09-30 | $204,230 | 32,213 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $288,903 | 36,803 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $258,115 | 37,354 | Shares | Defined | 2023-05-18 | |
| 2022-12-31 | $177,868 | 27,923 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $141,864 | 26,078 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $111,245 | 25,515 | Shares | Defined | 2022-08-11 | |
| 2021-06-30 | $227,375 | 79,502 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $93,547 | 34,776 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $35,385 | 11,995 | Shares | Defined | 2021-02-19 | |
| 2020-09-30 | $49,687 | 10,099 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $199,241 | 23,663 | Shares | Defined | 2020-08-11 | |
| 2020-03-31 | $37,104 | 7,878 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||